“…Several dosage schemes were used: a fixed dosage of 2.5 mg ICG was used in nine studies [16, 26, 27, 31, 33, 35, 37–39], a dosage of 0.05 mg/kg bodyweight was used in six studies [28–30, 32, 34, 40], a dosage of 0.5 mg/kg bodyweight was used in two studies [25, 36] and two studies reported other dosage schemes [15, 41]. For analysis of biliary tract identification, the studies providing information on dosage scheme were stratified by fixed dosage (2.5 mg) and dosage per kilogram bodyweight (0.05 mg/kg) as given in Table 2.…”